Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China flag China · Delayed Price · Currency is CNY
7.69
+0.02 (0.26%)
Apr 22, 2026, 1:35 PM CST

SHE:002566 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
63.5571.48487.73343.26219.7
Short-Term Investments
----30.08
Trading Asset Securities
507.57459.67102.9859.8470.16
Cash & Short-Term Investments
571.13531.15590.72403.11319.94
Cash Growth
7.53%-10.08%46.54%25.99%11.48%
Accounts Receivable
214.89199.03198.53264254.84
Other Receivables
20.915.3611.7522.2339.61
Receivables
235.79214.39210.28286.23294.45
Inventory
1,5811,6261,6171,6031,597
Other Current Assets
9.873.7513.3210.1710.53
Total Current Assets
2,3982,3762,4312,3032,222
Property, Plant & Equipment
417.13450.34483.66526.11501.49
Long-Term Investments
-15.23---
Goodwill
1.911.911.911.911.91
Other Intangible Assets
108.66111.35114.18117.03119.96
Long-Term Deferred Tax Assets
15.8513.1512.6214.215.2
Long-Term Deferred Charges
1.542.152.023.072.99
Other Long-Term Assets
16.730.761.271.681.04
Total Assets
2,9602,9713,0472,9672,864
Accounts Payable
11.691324.8624.3319.81
Accrued Expenses
7.6722.2632.5130.6848.11
Short-Term Debt
288.23290.28470.43430.43397.86
Current Portion of Long-Term Debt
2.70.42--2.55
Current Portion of Leases
-2.982.343.293.31
Current Income Taxes Payable
9.180.012.780.645.55
Current Unearned Revenue
14.775.4911.0124.5116.72
Other Current Liabilities
49.8631.5545.9174.2939.84
Total Current Liabilities
384.1366589.85588.16533.75
Long-Term Debt
129.7149.7---
Long-Term Leases
5.346.214.039.8211.46
Long-Term Unearned Revenue
108.87112.54118.69118.02120.85
Long-Term Deferred Tax Liabilities
2.342.771.741.170.02
Total Liabilities
630.35637.22714.3717.18666.08
Common Stock
330.95330.95330.95330.95330.95
Additional Paid-In Capital
834.69834.69834.69834.69834.69
Retained Earnings
1,0661,0701,068989.34916.17
Total Common Equity
2,2322,2362,2332,1552,082
Minority Interest
97.7697.8399.2694.45116.47
Shareholders' Equity
2,3292,3332,3322,2492,198
Total Liabilities & Equity
2,9602,9713,0472,9672,864
Total Debt
425.97449.59476.8443.55415.18
Net Cash (Debt)
145.1681.56113.92-40.44-95.24
Net Cash Growth
77.97%-28.40%---
Net Cash Per Share
0.440.250.34-0.12-0.29
Filing Date Shares Outstanding
331.23330.95330.95330.95330.95
Total Common Shares Outstanding
331.23330.95330.95330.95330.95
Working Capital
2,0142,0101,8411,7141,688
Book Value Per Share
6.746.766.756.516.29
Tangible Book Value
2,1212,1222,1172,0361,960
Tangible Book Value Per Share
6.406.416.406.155.92
Buildings
-548.14548.14545.7400.71
Machinery
-353.49359357.13321.57
Construction In Progress
---1.98119.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.